Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rilpivirine plus ritonavir-boosted darunavir in therapy-naive HIV-1 patients
2012-002663-10Phase 4Completed
- Sponsor
- St Stephen's AIDS Trust
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of rilpivirine, darunavir and ritonavir in Human immunodeficiency virus infection type 1, sponsored by St Stephen's AIDS Trust. Primary endpoint: Virologic suppression at week 48. Started Oct 2012; status: completed.
02
Drugs
rilpivirinedarunavirritonavir
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2012-002663-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002663-10.